Actress Suchitra Krishnamoorthi has alleged that ICICI Lombard General Insurance denied a hospitalization claim due to undisclosed pre-existing conditions. The insurer stated that claims are processed according to policy terms and requested specific details for a fresh review.
ICICI Lombard General Insurance is currently addressing a public allegation regarding the rejection of a health insurance claim. Actress Suchitra Krishnamoorthi recently claimed on social media that the insurer denied her reimbursement request for hospitalization, citing a pre-existing ulcer condition that she allegedly failed to disclose when she first purchased the policy. The actor has maintained that she did not have this health issue at the time the insurance contract was issued.
In response to the public concern, the insurance company stated that it maintains a process for assessing claims based on policy terms and regulatory guidelines set by the Insurance Regulatory and Development Authority of India (IRDAI). The company noted that it had communicated with the customer previously and has not received any new claim documentation related to this specific instance. The insurer has encouraged the customer to provide relevant details so that the case can be verified again.
For investors and policyholders, this event highlights the importance of the disclosure process during the purchase of health insurance. Insurance companies rely on information provided by the customer at the inception of the policy to calculate risk and premiums. If a claim is later rejected due to a lack of disclosure of pre-existing health conditions, it often leads to disputes.
From a business perspective, health insurance companies generally follow strict underwriting and claim-settlement protocols to ensure financial stability and compliance with regulatory standards. Investors typically monitor how efficiently a company handles such claim disputes, as a high volume of unresolved customer grievances or negative public perception can influence brand trust and regulatory scrutiny. The company maintains that its internal processes are designed for fairness and timely resolution.
Moving forward, the primary monitorable for this specific matter will be whether the insurer and the customer reach a resolution through the official grievance redressal mechanism. Investors may continue to track the company’s overall claim settlement ratio, which is a standard industry metric that measures the percentage of claims paid against those reported, as a proxy for operational efficiency and customer service quality.